Provided by Tiger Fintech (Singapore) Pte. Ltd.

Teladoc Health Inc.

7.27
+0.34004.91%
Post-market: 7.25-0.0200-0.28%19:58 EDT
Volume:5.28M
Turnover:38.29M
Market Cap:1.28B
PE:-1.24
High:7.42
Open:7.07
Low:7.05
Close:6.93
Loading ...

Hims & Hers vs. Teladoc: Which Telehealth Stock Is the Better Buy Now?

Zacks
·
01 May

Teladoc (TDOC) Reports Earnings Tomorrow: What To Expect

StockStory
·
29 Apr

Teladoc Health Is Maintained at Neutral by Citigroup

Dow Jones
·
25 Apr

Citi cuts Teladoc target, opens ‘upside 30-day short-term view’

TIPRANKS
·
25 Apr

Stock Track | Teladoc Health Soars 5.15% as Bullish Options Activity Signals Positive Sentiment

Stock Track
·
23 Apr

Stock Track | Teladoc Health Soars 5.15% on Bullish Options Activity

Stock Track
·
23 Apr

Teladoc Health Inc : Jefferies Cuts Target Price to $8.00 From $10.00

THOMSON REUTERS
·
21 Apr

Stock Track | Teladoc Health Plummets 5.12% as Jefferies Cuts Price Target on BetterHelp Concerns

Stock Track
·
21 Apr

Analysts Conflicted on These Healthcare Names: Cytokinetics (CYTK) and Teladoc (TDOC)

TIPRANKS
·
21 Apr

Teladoc price target lowered to $8 from $10 at Jefferies

TIPRANKS
·
21 Apr

Teladoc Health to Announce First Quarter 2025 Financial Results

GlobeNewswire
·
17 Apr

Hims & Hers Stock Gains 5.8% in 3 Months: Here's How to Play it

Zacks
·
16 Apr

Teladoc Health Is Maintained at Neutral by B of A Securities

Dow Jones
·
11 Apr

Teladoc’s Uncertain Growth Amid Declining User Base and Strategic Initiatives

TIPRANKS
·
11 Apr

Teladoc (TDOC) Stock Moves -0.97%: What You Should Know

Zacks
·
09 Apr

Teladoc Health Introduces Next Generation Cardiometabolic Health Program

GlobeNewswire
·
08 Apr

Teladoc Health (NYSE:TDOC) Expands Connected Care Partnerships Amid US Tariff Concerns

Simply Wall St.
·
03 Apr

Teladoc call volume above normal and directionally bullish

TIPRANKS
·
03 Apr

Hims & Hers to Sell Lilly's Weight-Loss Drug on Its Telehealth Platform

Reuters
·
02 Apr

BUZZ-Hims & Hers rises after plan to sell Eli Lilly's weight loss drug on its platform

Reuters
·
02 Apr